Incidence of primary hepatitis C infection and risk factors for transmission in an Australian prisoner cohort

Teutsch, Suzy; Luciani, Fabio; Scheuer, Nicolas; McCredie, Luke; Hosseiny, Parastu; Rawlinson, William; Kaldor, John; Dore, Gregory J.; Dolan, Kate; Ffrench, Rosemary; Lloyd, Andrew; Haber, Paul; Levy, Michael
January 2010
BMC Public Health;2010, Vol. 10, p633
Academic Journal
Background: Hepatitis C virus (HCV) infection is common in prisoner populations, particularly those with a history of injecting drug use (IDU). Previous studies of HCV incidence have been based on small case numbers and have not distinguished risk events in prison from those in the community. Methods: HCV incidence was examined in a longitudinal cohort of 488 Australian prisoners with a history of IDU and documented to be seronegative within 12 months prior to enrolment. Inmates were tested for anti-HCV antibodies and viremia, and interviewed about demographic and behavioral risk factors for transmission. Results: The cohort was predominantly male (65%) with high rates of prior imprisonment (72%) and tattooing (73%), as well as longstanding IDU (mean 8.5 years). Ninety-four incident HCV cases were identified (incidence 31.6 per 100 person years). Independent associations were observed between incident infection and prior imprisonment (p = 0.02) and tattooing (p = 0.03), and surprisingly also with methadone maintenance treatment (MMT) (p < 0.001). Conclusions: High rates of new HCV infection were found in this prisoner cohort reflecting their substantive risk behavior profile, despite having remained uninfected for many years. The association with MMT is challenging and highlights the need for better understanding of prison-specific HCV transmission risks, as well as the uptake and effectiveness of prevention programs.


Related Articles

  • Molecular epidemiology of hepatitis C virus among injection drug users in Iran: a slight change in prevalence of HCV genotypes over time. Samimi-Rad, Katayoun; Nasiri Toosi, Mohsen; Masoudi-nejad, Ali; Najafi, Ali; Rahimnia, Ramin; Asgari, Fatemeh; Shabestari, Alireza; Hassanpour, Gholamreza; Alavian, Seyed-Moayed; Asgari, Freshteh // Archives of Virology;Oct2012, Vol. 157 Issue 10, p1959 

    Injecting drug users (IDUs) are the main at-risk population for hepatitis C virus (HCV) transmission. We studied HCV infection, risk factors, and genotype distribution in relation to the year of first injection among Iranian IDUs. Of a total of 126 specimens positive for HCV antibody, 93 (74 %)...

  • Use of Enhanced Surveillance for Hepatitis C Virus Infection to Detect a Cluster Among Young Injection-Drug Users--New York, November 2004-April 2007. Leuchner, L.; Lindstrom, H.; Burstein, G. R.; Mulhern, K. E.; Rocchio, E. M.; Johnson, G.; Schaffzin, J.; Smith, P. // JAMA: Journal of the American Medical Association;7/2/2008, Vol. 300 Issue 1, p34 

    The article discusses a report from the U.S. Centers for Disease Control and Prevention concerning the surveillance of hepatitis C virus (HCV) infections among young injection-drug users (IDUs) in New York State between November 2004 and April 2007 conducted by the New York State Department of...

  • Acute Hepatitis C: A Window of Opportunity. Thomas, David L. // Clinical Infectious Diseases;6/15/2006, Vol. 42 Issue 12, p1671 

    The author comments on the transmission of hepatitis C virus (HCV) in which infections occur most frequently in injection drug users in the U.S. The majority of infections involve sharing of HCV contaminated needles or other drug use equipment. It was also stated that chronic hepatitis C in...

  • Hepatitis C Virus Genotype Diversity among Intravenous Drug Users in Yunnan Province, Southwestern China. Zhang, Zhihui; Yao, Yufeng; Wu, Wenlong; Feng, Ruilin; Wu, Zhongxiang; Cun, Wei; Dong, Shaozhong // PLoS ONE;Dec2013, Vol. 8 Issue 12, p1 

    Background: Recently, high proportions (15.6%–98.7%) of intravenous drug users (IDUs) in China were found to be positive for hepatitis C virus (HCV). Yunnan Province is located in southwestern China and borders one of the world's most important opium-producing regions, thus it is an...

  • Baja prevalencia de la infección por el virus de la hepatitis C en una población de reclusos, Maracaibo, Venezuela. Monsalve-Castillo, Francisca; Chacín-Bonilla, Leonor; Atencio, Ricardo José; Porto, Leticia Denys; Costa-León, Luciana Ana; Estévez, Jesús Enrique; Callejas-Valero, Diana Estela // Biomédica: Revista del Instituto Nacional de Salud;dic2009, Vol. 29 Issue 4, p647 

    Introduction. The high risk behaviors observed in prison centers have favored the transmission of hepatitis C virus infection. The main risk factor to acquire hepatitis C virus infection seems to be the use of intravenous drugs. In Venezuela, the prevalence of the infection in these centers is...

  • Characteristics of Hepatitis C Virus among Intravenous Drug Users in Iceland. Löve, Arthur; Sigurdsson, Jon R.; Stanzeit, Barbara; Briem, Haraldur; Rikardsdottir, Hugrun; Widell, Anders // American Journal of Epidemiology;1996, Vol. 143 Issue 6, p631 

    According to antibody analysis, approximately two of every three intravenous drug users in Iceland have become infected with hepatitis C virus (HCV). In this study, serum samples from 55 HCV antibody-positive intravenous drug users (39 males and 16 females) were analyzed by polymerase chain...

  • Changes in Blood-borne Infection Risk Among Injection Drug Users. Mehta, Shruti H.; Astemborski, Jacqueline; Kirk, Gregory D.; Strathdee, Steffanie A.; Nelson, Kenrad E.; Vlahov, David; Thomas, David L. // Journal of Infectious Diseases;Mar2011, Vol. 203 Issue 5, p587 

    Background. Population-level hepatitis C virus (HCV) infection incidence is a surrogate for community drug-related risk.Methods. We characterized trends in human immunodeficiency virus (HIV) and HCV infection incidence and HCV infection prevalence among injection drug users (IDUs) recruited over...

  • Injection Drug Use Facilitates Hepatitis C Virus Infection of Peripheral Blood Mononuclear Cells. Resti, Massimo; Azzari, Chiara; Moriondo, Maria; Betti, Letizia; Storzi, Idanna; Novembre, Elio; Vierucci, Alberto // Clinical Infectious Diseases;8/1/2002, Vol. 35 Issue 3, p236 

    Infection of peripheral blood mononuclear cells (PBMCs) with hepatitis C virus (HCV) has been demonstrated and has been found to play a role in relapse of HCV disease and vertical transmission of HCV. Injection drug use is thought to impair function of the immune system and induce tolerance to...

  • Hepatitis C Virus Infection: Prevalence, Risk Factors, and Prevention Opportunities among Young Injection Drug Users in Chicago, 1997-1999. Thorpe, Lorna E.; Ouellet, Lawrence J.; Levy, Jennie R.; Williams, Ian T.; Monterroso, Edgar R. // Journal of Infectious Diseases;12/1/2000, Vol. 182 Issue 6 

    The prevalence, risk factors, and prevention opportunities of hepatitis C virus (HCV) in-fection were studied in a large sample of 698 young adult injection drug users (IDUs) in Chicago, 18-30 years old. Participants were recruited between 1997 and 1999 by using street outreach, targeted...


Read the Article


Sorry, but this item is not currently available from your library.

Try another library?
Sign out of this library

Other Topics